Literature DB >> 2527866

Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients.

N Lahat1, J Rivlin, T C Iancu.   

Abstract

The role of B cells and regulatory T cells in the reduced in vitro IgG synthesis of cystic fibrosis (CF) patients was studied. Intact proportion, proliferation, and differentiation of B cells and reduced suppressor and helper T-cell function were found. To explore the T-cell defects further, CF sera or supernatant derived from Pseudomonas aeruginosa cultures (PA supernatant) was added to the relevant T helper- and suppressor-cell assays. Both CF sera derived from PA-positive patients and PA supernatant interfered with the appearance of interleukin 2 (IL-2) receptors and with the functional enhancement caused by exogenously added IL-2. PA-negative CF patients, however, also had functional T-cell defects and inhibitory sera, but these sera did not affect IL-2 pathways. Thus different serum factors and intrinsic T-cell defects in CF patients are suggested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527866     DOI: 10.1007/bf00918660

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  34 in total

1.  SPECIFIC ISOANTIBODIES IN CYSTIC FIBROSIS. A STUDY OF SERUM AND BRONCHIAL MUCUS.

Authors:  A A STEIN; F C MANLAPAS; K F SOIKE; P R PATTERSON
Journal:  J Pediatr       Date:  1964-10       Impact factor: 4.406

Review 2.  The role of T lymphocytes in autoimmune thyroid disease.

Authors:  A J Ahmann; K D Burman
Journal:  Endocrinol Metab Clin North Am       Date:  1987-06       Impact factor: 4.741

3.  Impairment of cell-mediated immune responses by Pseudomonas aeruginosa.

Authors:  G L Floersheim; W H Hopff; M Gasser; K Bucher
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

4.  Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; P Chase; S H Polmar
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

5.  Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation.

Authors:  K Kumagai; K Itoh; S Hinuma; M Tada
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

6.  The effect of phenazine methosulfate-ascorbate on bacterial active transport and adenosine triphosphate formation: inhibition of Pseudomonas aeruginosa and stimulation of Escherichia coli.

Authors:  R G Eagon; T W Hodge; J B Rake; J M Yarbrough
Journal:  Can J Microbiol       Date:  1979-07       Impact factor: 2.419

7.  Association of cystic fibrosis with allergy.

Authors:  J O Warner; B W Taylor; A P Norman; J F Soothill
Journal:  Arch Dis Child       Date:  1976-07       Impact factor: 3.791

8.  Systemic immune response of patients with active pulmonary sarcoidosis.

Authors:  R P Baughman; P E Hurtubise
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

9.  Hypogammaglobulinemia in patients with cystic fibrosis.

Authors:  W J Matthews; M Williams; B Oliphint; R Geha; H R Colten
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  7 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.

Authors:  C H Mody; D E Buser; R M Syme; D E Woods
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

3.  Modulation of Treg function improves adenovirus vector-mediated gene expression in the airway.

Authors:  Y Nagai; M P Limberis; H Zhang
Journal:  Gene Ther       Date:  2014-01-02       Impact factor: 5.250

4.  Activation of CFTR chloride current by nitric oxide in human T lymphocytes.

Authors:  Y J Dong; A C Chao; K Kouyama; Y P Hsu; R C Bocian; R B Moss; P Gardner
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

5.  Gammadelta T lymphocytes from cystic fibrosis patients and healthy donors are high TNF-alpha and IFN-gamma-producers in response to Pseudomonas aeruginosa.

Authors:  Salvador Raga; M Rosa Julià; Catalina Crespí; Joan Figuerola; Natalia Martínez; Joan Milà; Núria Matamoros
Journal:  Respir Res       Date:  2003-09-08

6.  A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense.

Authors:  Emma Svedin; Renata Utorova; Michael H Hühn; Pär G Larsson; Virginia M Stone; Manasa Garimella; Katharina Lind; Thomas Hägglöf; Terezia Pincikova; Olli H Laitinen; Gerald M McInerney; Bob Scholte; Lena Hjelte; Mikael C I Karlsson; Malin Flodström-Tullberg
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

Review 7.  Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.

Authors:  Deepshikha Verma; Edward D Chan; Diane J Ordway
Journal:  Vaccines (Basel)       Date:  2020-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.